Two part (double-blind inclisiran versus placebo [Year 1]followed by open-label inclisiran [Year 2]) randomizedmulticenter study to evaluate safety, tolerability, andefficacy of inclisiran in adolescents (12 to less than 18years) with heterozygous familial hypercholesterolemiaand elevated LDL-cholesterol (ORION-16) | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

Two part (double-blind inclisiran versus placebo [Year 1]followed by open-label inclisiran [Year 2]) randomizedmulticenter study to evaluate safety, tolerability, andefficacy of inclisiran in adolescents (12 to less than 18years) with heterozygous familial hypercholesterolemiaand elevated LDL-cholesterol (ORION-16)

Gökçay G. F. (Yürütücü), Karaca M., Balcı M. C.

Diğer Uluslararası Fon Programları, 2020 - 2022

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Eylül 2020
Bitiş Tarihi: Aralık 2022